Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Human Gene Therapy|October 16, 2015
Prevention of Lethal Murine Hypophosphatasia by Neonatal Ex Vivo Gene Therapy Using Lentivirally Transduced Bone Marrow CellsOsamu Iijima, Koichi Miyake, Atsushi Watanabe, et al.
Journal of Vascular Research|December 22, 2007
Insulin activates ATP-sensitive potassium channels via phosphatidylinositol 3-kinase in cultured vascular smooth muscle cellsSonoko Yasui, Kazuaki Mawatari, Takashi Kawano, et al.
Frontiers in Immunology|December 28, 2023
Case Report: The leopard sign as a potential characteristic of chronic granulomatous disease-associated colitis, unrelated to colitis severityTakuro Nishikawa, Takahiro Tomoda, Aki Nakamura, et al.
Frontiers in Immunology|August 18, 2025
Case Report: GATA2 deficiency in two families with novel frameshift variants highlighting phenotypic diversity and need for early diagnosisMiko Morimoto, Takuro Nishikawa, Atsushi Hijikata, et al.
Frontiers in Immunology|December 5, 2024
Perspectives in newborn screening for SCID in Japan. Case report: newborn screening identified X-linked severe combined immunodeficiency with a novel IL2RG variantShiro Beppu, Takuro Nishikawa, Dan Tomomasa, et al.
Molecular Therapy. Methods & Clinical Development|February 24, 2016
Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vectorAki Nakamura-Takahashi, Koichi Miyake, Atsushi Watanabe, et al.
Biochimica Et Biophysica Acta|November 6, 2008
Identification of cis-acting promoter sequences required for expression of the glycerol-3-phosphate acyltransferase 1 gene in miceMasaki Yoshida, Nagakatsu Harada, Hironori Yamamoto, et al.
Modern Rheumatology|October 8, 2025
Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosusHitoshi Irabu, Asami Ohara, Aki Nakamura, et al.
Disease Models & Mechanisms|December 1, 2021
A new mouse model of Ehlers-Danlos syndrome generated using CRISPR/Cas9-mediated genomic editingYuko Nitahara-Kasahara, Shuji Mizumoto, Yukiko U Inoue, et al.
Pageof 6